查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球心臟去顫器市場（按產品、患者類型、最終用戶和地區分類）- 預測至 2030 年
市場調查報告書
商品編碼
1794019

全球心臟去顫器市場（按產品、患者類型、最終用戶和地區分類）- 預測至 2030 年

Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 296 Pages | 訂單完成後即時交付

價格

全球心臟去顫器市場預計將從 2025 年的 119.9 億美元成長到 2030 年的 164.4 億美元，預測期內的複合年成長率為 6.5%。

調查範圍
調查年份 2024-2030
基準年 2024
預測期 2025-2030
對價單位 金額（十億美元）
部分 按產品、患者類型、最終用戶和地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

心臟去顫器市場的成長得益於心血管疾病患者人口比例的不斷增加、心臟去顫器技術的進步、免費培訓和計畫的提供以及公共和私人組織為增加公共場所心臟去顫器(PAD) 的採用而採取的越來越多的舉措。然而，植入式和自動體外心臟心臟去顫器的問題以及頻繁的產品心臟去顫器阻礙了市場的成長。

除顫器市場-IMG1

心臟去顫器市場大致按產品類型分為植入式心臟去顫器(ICD) 和體外心臟去顫器。 ICD 進一步分為經靜脈植入式心臟去顫器和植入式心臟去顫器，而體外心臟去顫器進一步分為手動 AED、自動 AED 和穿戴式式心臟去顫器。 ICD 部門在 2024 年佔據全球心臟去顫器市場佔有率的最大佔有率，這得益於植入式心臟去顫器的技術進步、循環系統對皮下 ICD 益處的認知不斷提高以及技術先進的 ICD 的推出。

心臟去顫器市場根據患者類型細分為成人和兒童。成人患者群體預計將在2024年佔據全球心臟去顫器市場的主導地位。成年人心血管疾病盛行率的上升、更容易發生心臟麻痹的老年人口的快速成長，以及成人患者植入ICD的數量的增加，預計將推動該領域的成長。

根據地區分類，全球心臟去顫器市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。預計北美將在預測期內佔據顯著的市場佔有率，原因包括先進心臟去顫器的普及率不斷提高、政府加大力度為心臟麻痹患者提供必要護理、市場參與企業的穩固立足點、優惠的報銷計劃以及冠狀動脈疾病發病率不斷上升等因素。

本報告研究了全球心臟去顫器市場，按產品、患者類型、最終用戶和地區進行細分，並介紹了參與市場的公司。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章市場概述

  • 介紹
  • 市場動態
  • 產業趨勢
  • 影響客戶業務的趨勢/中斷
  • 定價分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 投資金籌措場景
  • 技術分析
  • 專利分析
  • 貿易分析
  • 2025-2026年主要會議和活動
  • 監管狀況
  • 波特五力分析
  • 主要相關人員和採購標準
  • 贖回情景
  • 未滿足的需求/最終用戶期望
  • 人工智慧/產生人工智慧對心臟去顫器市場的影響
  • 2025年美國關稅的影響

心臟去顫器市場（依產品）

  • 介紹
  • 植入式心臟去顫器
  • 體外心臟去顫器

心臟去顫器市場（依患者類型）

  • 介紹
  • 成年患者
  • 兒科患者

心臟去顫器市場（依最終用戶）

  • 介紹
  • 醫院和診所
  • 心臟中心
  • 院前醫療環境
  • 公共接取市場
  • 居家照護
  • 其他

心臟去顫器市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第10章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2022-2024年收益分析
  • 2024年市場佔有率分析
  • 估值和財務指標
  • 品牌/產品比較
  • 公司估值矩陣：2024 年關鍵參與企業
  • 公司估值矩陣：Start-Ups/中小企業，2024 年
  • 競爭場景

第11章：公司簡介

  • 主要參與企業
    • MEDTRONIC
    • BOSTON SCIENTIFIC CORPORATION
    • ABBOTT
    • ASAHI KASEI CORPORATION
    • STRYKER
    • KONINKLIJKE PHILIPS NV
    • MICROPORT SCIENTIFIC CORPORATION
    • NIHON KOHDEN CORPORATION
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • BIOTRONIK
    • CU MEDICAL SYSTEMS CO., LTD.
    • METSIS MEDIKAL
    • MEDIANA CO, LTD.
    • PROGETTI SRL
    • SCHILLER AG
  • 其他公司
    • BPL MEDICAL TECHNOLOGIES
    • METRAX GMBH
    • MS WESTFALIA GMBH
    • BEXEN CARDIO
    • SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
    • AVIVE SOLUTIONS
    • AMI ITALIA
    • CORPULS
    • ALLIED MEDICAL LTD.
    • AXION CONCERN LLC

第12章 附錄

Product Code: MD 3124

The global defibrillator market is expected to reach USD 16.44 billion by 2030 from USD 11.99 billion in 2025, at a CAGR of 6.5% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Patient Type, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The growth in the defibrillator market is driven by the increasing proportion of the population with cardiovascular diseases, technological advancements in defibrillators, and rising initiatives by public and private organizations to provide free training and programs, as well as enhance the implementation of public access defibrillators (PADs). However, issues related to implantable and automated external defibrillators and frequent product recalls have impeded market growth.

Defibrillator Market - IMG1

The implantable cardioverter defibrillators segment accounted for the largest share of the global market in 2024.

Based on product, the defibrillator market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. ICDs are further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual AEDs, automated AEDs, and wearable defibrillators. The ICDs segment accounted for the largest global defibrillator market share in 2024. Technological advancements in implantable defibrillators, rising awareness among cardiologists about the benefits pertaining to subcutaneous ICDs, and the launch of technologically advanced ICDs.

The adult segment dominated the defibrillator market based on the patient type in 2024.

The defibrillator market is segmented into adult and pediatric patients based on patient type. The adult patients segment dominated the global defibrillator market in 2024. The increasing incidence of cardiovascular disease in the adult population, rapid growth in the geriatric population, which is highly susceptible to sudden cardiac arrest, and the increasing number of implantations of ICDs in adult patients are likely to fuel the growth of the segment.

North America is expected to account for the highest market share in the defibrillator market during the forecast period.

Based on the region, the global defibrillator market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to factors such as the rising adoption of advanced defibrillators, increasing efforts by governments to provide the necessary care to cardiac arrest patients, the strong foothold of market players, favorable reimbursement programs, and an increase in the incidence of coronary artery diseases.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
  • By Designation: C Level (35%), Director Level (25%), and Others (40%)
  • By Region: North America (40%), Asia Pacific (25%), Europe (20%), Latin America (10%), and Middle East & Africa (5%)

Prominent companies include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).

Research Coverage

This research report categorizes the defibrillator market by Product {Implantable cardioverter defibrillators [Transvenous implantable cardioverter defibrillators (Biventricular ICDS/cardiac resynchronization therapy defibrillators, dual-chamber ICDS, and single-chamber ICDS)], Subcutaneous implantable cardioverter defibrillators) External defibrillators [Manual External defibrillators, Automated external defibrillators (semi-automated external defibrillators, fully automated external defibrillators)], Wearable cardioverter defibrillators}, Patient type (Adult, Pediatric), End Users (Hospitals & Clinics, Cardiac centers, Prehospital settings, Public access markets, Home care settings, and Other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the defibrillators market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will help established firms, new entrants, and smaller firms gauge the pulse of the market, which in turn would help them gain a more significant share of the market. Firms purchasing the report could use one or any combination of the strategies mentioned below to strengthen their position in the market.

This report provides insights into the following pointers:

  • Analysis of key drivers (rising prevalence of cardiovascular disease, increase in geriatric patient population, a strong focus of government to boost the installation of public access defibrillators, rising defibrillators training & programs, and expanding healthcare infrastructure), restraints (frequent product recalls, issues related to implantable and automated external defibrillators), opportunities (emerging countries, ongoing developments in ICDs/CRT-Ds, mergers and acquisitions among market players), and challenges (frequent product recalls and lack of awareness about the cardiac arrest in emerging countries) influencing the growth of the defibrillators market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the defibrillator market
  • Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the defibrillator market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the defibrillator market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 END-USER-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
    • 2.2.4 TOP-DOWN APPROACH
    • 2.2.5 GROWTH RATE PROJECTIONS
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DEFIBRILLATOR MARKET OVERVIEW
  • 4.2 ASIA PACIFIC DEFIBRILLATOR MARKET, BY COUNTRY AND END USER
  • 4.3 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATOR MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of cardiovascular diseases
      • 5.2.1.2 Increasing focus on public-access defibrillators
      • 5.2.1.3 Training and awareness programs on defibrillators
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Frequent product recalls
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Untapped growth potential in emerging markets
      • 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Inadequate awareness of sudden cardiac arrest and limited access to healthcare
      • 5.2.4.2 Challenges associated with pricing pressure
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 NEXT GEN AI-ENABLED PATCH WEARABLE CARDIOVERTER DEFIBRILLATORS
    • 5.3.2 CONNECTED AED ECOSYSTEM
    • 5.3.3 EXPANSION IN EMERGING MARKETS AND PUBLIC ACCESS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Electrodes and gel pad technology
      • 5.10.1.2 Handheld portable defibrillator
    • 5.10.2 COMPLEMENTARY TECHNOLOGIES
      • 5.10.2.1 Cardiopulmonary Resuscitation (CPR) feedback technology
      • 5.10.2.2 Automated self-testing and device readiness monitoring
    • 5.10.3 ADJACENT TECHNOLOGIES
      • 5.10.3.1 Electronic Health Record (EHR) integration
  • 5.11 PATENT ANALYSIS
    • 5.11.1 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 IMPORT DATA FOR HS CODE 901890
    • 5.12.2 EXPORT DATA FOR HS CODE 901890
  • 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.14 REGULATORY LANDSCAPE
    • 5.14.1 REGULATORY FRAMEWORK
      • 5.14.1.1 North America
        • 5.14.1.1.1 US
        • 5.14.1.1.2 Canada
      • 5.14.1.2 Europe
      • 5.14.1.3 Asia Pacific
      • 5.14.1.4 Latin America
      • 5.14.1.5 Middle East & Africa
    • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 BARGAINING POWER OF SUPPLIERS
    • 5.15.2 BARGAINING POWER OF BUYERS
    • 5.15.3 THREAT OF NEW ENTRANTS
    • 5.15.4 THREAT OF SUBSTITUTES
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 REIMBURSEMENT SCENARIO
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.19 IMPACT OF AI/GEN AI ON DEFIBRILLATOR MARKET
    • 5.19.1 INTRODUCTION
    • 5.19.2 MARKET POTENTIAL OF AI IN DEFIBRILLATORS
    • 5.19.3 AI USE CASES
    • 5.19.4 KEY COMPANIES IMPLEMENTING AI
  • 5.20 IMPACT OF 2025 US TARIFF
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON COUNTRY/REGION
    • 5.20.5 IMPACT ON END-USE SEGMENTS

6 DEFIBRILLATOR MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators
        • 6.2.1.1.1 Growing improvements in battery technology to boost market
      • 6.2.1.2 Dual-chamber ICDs
        • 6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market
      • 6.2.1.3 Single-chamber ICDs
        • 6.2.1.3.1 Utilization of single-chamber ICDs for atrial monitoring to support growth
    • 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 6.2.2.1 Increasing preference for less-invasive approach to augment growth
  • 6.3 EXTERNAL DEFIBRILLATORS
    • 6.3.1 MANUAL EXTERNAL DEFIBRILLATORS
      • 6.3.1.1 High portability and compact design to foster growth
    • 6.3.2 AUTOMATED EXTERNAL DEFIBRILLATORS
      • 6.3.2.1 Semi-automated external defibrillators
        • 6.3.2.1.1 Growing initiatives for emergency medical services to fuel market
      • 6.3.2.2 Fully automated external defibrillators
        • 6.3.2.2.1 Rising installation of defibrillators in public places to favor growth
    • 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
      • 6.3.3.1 Increasing launches of wearable defibrillators to facilitate growth

7 DEFIBRILLATOR MARKET, BY PATIENT TYPE

  • 7.1 INTRODUCTION
  • 7.2 ADULT PATIENTS
    • 7.2.1 INCREASING GERIATRIC POPULATION AND RISING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 7.3 PEDIATRIC PATIENTS
    • 7.3.1 RISING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT GROWTH

8 DEFIBRILLATOR MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & CLINICS
    • 8.2.1 HIGH VOLUME OF CARDIAC PROCEDURES TO EXPEDITE GROWTH
  • 8.3 CARDIAC CENTERS
    • 8.3.1 INCREASING CARDIOVASCULAR CASELOAD AND NEED FOR SPECIALIZED CARE TO BOOST MARKET
  • 8.4 PREHOSPITAL SETTINGS
    • 8.4.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO PROMOTE GROWTH
  • 8.5 PUBLIC-ACCESS MARKETS
    • 8.5.1 GROWING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET
  • 8.6 HOME CARE SETTINGS
    • 8.6.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO FOSTER GROWTH
  • 8.7 OTHER END USERS

9 DEFIBRILLATOR MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 High implant rates to contribute to growth
    • 9.2.3 CANADA
      • 9.2.3.1 High burden of cardiovascular diseases to support growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Established healthcare system to favor growth
    • 9.3.3 UK
      • 9.3.3.1 Rising support from government & private organizations for accessibility of defibrillators to drive market
    • 9.3.4 FRANCE
      • 9.3.4.1 Favorable government initiatives to bolster growth
    • 9.3.5 ITALY
      • 9.3.5.1 High prevalence of out-of-hospital cardiac arrests to promote growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising aging population to stimulate growth
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Booming geriatric population to foster growth
    • 9.4.3 CHINA
      • 9.4.3.1 Rising incidence of strokes to expedite growth
    • 9.4.4 INDIA
      • 9.4.4.1 Growing prevalence of cardiovascular diseases and government initiatives to drive market
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing community access to defibrillators through policy and targeted funding to fuel market
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Robust digital ecosystem and government-led health programs to boost market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Rising obesity rates to accelerate growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing infrastructure development to facilitate growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Kingdom of Saudi Arabia (KSA)
        • 9.6.2.1.1 Expanding digital healthcare infrastructure to boost market
      • 9.6.2.2 United Arab Emirates (UAE)
        • 9.6.2.2.1 Increasing government investments for healthcare infrastructure to aid growth
      • 9.6.2.3 Rest of GCC Countries
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 STRATEGIES ADOPTED BY KEY PLAYERS
    • 10.2.2 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DEFIBRILLATOR MARKET
  • 10.3 REVENUE ANALYSIS, 2022-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.6 BRAND/PRODUCT COMPARISON
  • 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.7.1 STARS
    • 10.7.2 EMERGING LEADERS
    • 10.7.3 PERVASIVE PLAYERS
    • 10.7.4 PARTICIPANTS
    • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.7.5.1 Company footprint
      • 10.7.5.2 Region footprint
      • 10.7.5.3 Product footprint
      • 10.7.5.4 Patient type footprint
  • 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.8.1 PROGRESSIVE COMPANIES
    • 10.8.2 RESPONSIVE COMPANIES
    • 10.8.3 DYNAMIC COMPANIES
    • 10.8.4 STARTING BLOCKS
    • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.8.5.1 Detailed list of key startups/SMEs
      • 10.8.5.2 Competitive benchmarking of key startups/SMEs
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 10.9.2 EXPANSIONS
    • 10.9.3 DEALS
    • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 MEDTRONIC
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches and approvals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 BOSTON SCIENTIFIC CORPORATION
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 ABBOTT
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 MnM view
        • 11.1.3.3.1 Key strengths
        • 11.1.3.3.2 Strategic choices
        • 11.1.3.3.3 Weaknesses and competitive threats
    • 11.1.4 ASAHI KASEI CORPORATION
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 MnM view
        • 11.1.4.3.1 Key strengths
        • 11.1.4.3.2 Strategic choices
        • 11.1.4.3.3 Weaknesses and competitive threats
    • 11.1.5 STRYKER
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches and approvals
        • 11.1.5.3.2 Other developments
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Key strengths
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses and competitive threats
    • 11.1.6 KONINKLIJKE PHILIPS N.V.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Expansions
    • 11.1.7 MICROPORT SCIENTIFIC CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches and approvals
    • 11.1.8 NIHON KOHDEN CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Expansions
    • 11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches and approvals
        • 11.1.9.3.2 Other developments
    • 11.1.10 BIOTRONIK
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Expansions
    • 11.1.11 CU MEDICAL SYSTEMS CO., LTD.
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 METSIS MEDIKAL
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 MEDIANA CO, LTD.
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Other developments
    • 11.1.14 PROGETTI SRL
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Other developments
    • 11.1.15 SCHILLER AG
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Deals
        • 11.1.15.3.2 Other developments
  • 11.2 OTHER PLAYERS
    • 11.2.1 BPL MEDICAL TECHNOLOGIES
    • 11.2.2 METRAX GMBH
    • 11.2.3 MS WESTFALIA GMBH
    • 11.2.4 BEXEN CARDIO
    • 11.2.5 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
    • 11.2.6 AVIVE SOLUTIONS
    • 11.2.7 AMI ITALIA
    • 11.2.8 CORPULS
    • 11.2.9 ALLIED MEDICAL LTD.
    • 11.2.10 AXION CONCERN LLC

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 DEFIBRILLATOR MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 DEFIBRILLATOR MARKET: RISK ANALYSIS
  • TABLE 4 PERCENTAGE OF GLOBAL POPULATION AGED 65 YEARS, BY REGION, 2022 VS. 2030 VS. 2050
  • TABLE 5 PRODUCT RECALLS BY US FDA, 2021-2024
  • TABLE 6 AVERAGE SELLING PRICE TREND OF DEFIBRILLATORS, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 7 AVERAGE SELLING PRICE TREND OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS), BY REGION, 2022-2024 (USD)
  • TABLE 8 AVERAGE SELLING PRICE TREND OF EXTERNAL DEFIBRILLATORS, BY REGION, 2022-2024 (USD)
  • TABLE 9 DEFIBRILLATOR MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 10 DEFIBRILLATOR MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023-2025
  • TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 13 DEFIBRILLATOR MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 DEFIBRILLATOR MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DEFIBRILLATOR
  • TABLE 21 KEY BUYING CRITERIA FOR DEFIBRILLATOR, BY PRODUCT
  • TABLE 22 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US
  • TABLE 23 DEFIBRILLATOR MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES, 2024
  • TABLE 25 KEY PRODUCT-RELATED TARIFF EFFECTIVE DEFIBRILLATOR
  • TABLE 26 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA
  • TABLE 27 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
  • TABLE 28 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK
  • TABLE 29 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO
  • TABLE 30 DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 31 COMMERCIAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AVAILABLE IN MARKET
  • TABLE 32 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 33 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 35 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 COMMERCIAL EXTERNAL DEFIBRILLATORS AVAILABLE IN MARKET
  • TABLE 41 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 42 EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 50 DEFIBRILLATOR MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 DEFIBRILLATOR MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 53 DEFIBRILLATOR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 DEFIBRILLATOR MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 DEFIBRILLATOR MARKET FOR PREHOSPITAL SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 DEFIBRILLATOR MARKET FOR PUBLIC-ACCESS MARKETS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 DEFIBRILLATOR MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 DEFIBRILLATOR MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 DEFIBRILLATOR MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2023-2030 (THOUSAND)
  • TABLE 61 NORTH AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 69 US: KEY MACROECONOMIC INDICATORS
  • TABLE 70 US: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 71 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 72 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 US: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 US: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 CANADA: KEY MACROECONOMIC INDICATORS
  • TABLE 78 CANADA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 79 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 80 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 81 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 83 CANADA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 CANADA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 85 EUROPE: DEFIBRILLATOR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 EUROPE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 87 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 EUROPE: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 93 GERMANY: KEY MACROECONOMIC INDICATORS
  • TABLE 94 GERMANY: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 95 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 96 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 97 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 GERMANY: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 GERMANY: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 101 UK: KEY MACROECONOMIC INDICATORS
  • TABLE 102 UK: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 103 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 USD MILLION)
  • TABLE 105 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 UK: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UK: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 109 FRANCE: KEY MACROECONOMIC INDICATORS
  • TABLE 110 FRANCE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 111 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 FRANCE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 FRANCE: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 117 ITALY: KEY MACROECONOMIC INDICATORS
  • TABLE 118 ITALY: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 119 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 ITALY: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 ITALY: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 125 SPAIN: KEY MACROECONOMIC INDICATORS
  • TABLE 126 SPAIN: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 127 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 SPAIN: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 SPAIN: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 REST OF EUROPE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 134 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 148 JAPAN: KEY MACROECONOMIC INDICATORS
  • TABLE 149 JAPAN: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 150 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 JAPAN: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 JAPAN: DEFIBRILLATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 156 CHINA: KEY MACROECONOMIC INDICATORS
  • TABLE 157 CHINA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 158 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 CHINA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 CHINA: EXTERNAL DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 164 INDIA: KEY MACROECONOMIC INDICATORS
  • TABLE 165 INDIA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 166 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 INDIA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 INDIA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 172 AUSTRALIA: KEY MACROECONOMIC INDICATORS
  • TABLE 173 AUSTRALIA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 174 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 177 AUSTRALIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 AUSTRALIA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 AUSTRALIA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 180 SOUTH KOREA: KEY MACROECONOMIC INDICATORS
  • TABLE 181 SOUTH KOREA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 182 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 184 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 SOUTH KOREA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 186 SOUTH KOREA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 SOUTH KOREA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 188 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 189 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 195 LATIN AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 196 LATIN AMERICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 197 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 200 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 LATIN AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 LATIN AMERICA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 203 BRAZIL: KEY MACROECONOMIC INDICATORS
  • TABLE 204 BRAZIL: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 205 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 BRAZIL: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 BRAZIL: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 BRAZIL: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 211 MEXICO: KEY MACROECONOMIC INDICATORS
  • TABLE 212 MEXICO: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 213 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 MEXICO: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 MEXICO: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 MEXICO: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 219 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 220 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 REST OF LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 226 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 228 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 237 GCC COUNTRIES: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 242 KINGDOM OF SAUDI ARABIA (KSA): KEY MACROECONOMIC INDICATORS
  • TABLE 243 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 244 KINGDOM OF SAUDI ARABIA (KSA): IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 KINGDOM OF SAUDI ARABIA (KSA): TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 KINGDOM OF SAUDI ARABIA (KSA): EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 KINGDOM OF SAUDI ARABIA (KSA): AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 250 UAE: KEY MACROECONOMIC INDICATORS
  • TABLE 251 UAE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 252 UAE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 253 UAE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 254 UAE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 UAE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 UAE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 UAE: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 258 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 259 REST OF GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 REST OF GCC COUNTRIES: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 REST OF GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 REST OF GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 264 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 265 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 266 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 REST OF MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 268 REST OF MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 REST OF MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 270 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 272 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DEFIBRILLATOR MARKET
  • TABLE 273 IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICDS) MARKET: DEGREE OF COMPETITION
  • TABLE 274 EXTERNAL DEFIBRILLATOR MARKET: DEGREE OF COMPETITION
  • TABLE 275 DEFIBRILLATOR MARKET: REGION FOOTPRINT
  • TABLE 276 DEFIBRILLATOR MARKET: PRODUCT FOOTPRINT
  • TABLE 277 DEFIBRILLATOR MARKET: PATIENT TYPE FOOTPRINT
  • TABLE 278 DEFIBRILLATOR MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 279 DEFIBRILLATOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 280 DEFIBRILLATOR MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 281 DEFIBRILLATOR MARKET: EXPANSIONS, JANUARY 2022-MAY 2025
  • TABLE 282 DEFIBRILLATOR MARKET: DEALS, JANUARY 2022-MAY 2025
  • TABLE 283 DEFIBRILLATOR MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 284 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 285 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 286 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022- MAY 2025
  • TABLE 287 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 288 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 289 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022-MAY 2025
  • TABLE 290 ABBOTT: COMPANY OVERVIEW
  • TABLE 291 ABBOTT: PRODUCTS OFFERED
  • TABLE 292 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
  • TABLE 293 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
  • TABLE 294 STRYKER: COMPANY OVERVIEW
  • TABLE 295 STRYKER: PRODUCTS OFFERED
  • TABLE 296 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 297 STRYKER: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 298 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 299 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 300 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022-MAY 2025
  • TABLE 301 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 302 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 303 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 304 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 305 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 306 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 307 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 308 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 309 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MAY 2025
  • TABLE 310 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 311 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 312 BIOTRONIK: PRODUCTS OFFERED
  • TABLE 313 BIOTRONIK: EXPANSIONS, JANUARY 2022-MAY 2025
  • TABLE 314 CU MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
  • TABLE 315 CU MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
  • TABLE 316 METSIS MEDIKAL: COMPANY OVERVIEW
  • TABLE 317 METSIS MEDIKAL: PRODUCTS OFFERED
  • TABLE 318 MEDIANA CO., LTD.: COMPANY OVERVIEW
  • TABLE 319 MEDIANA CO., LTD.: PRODUCTS OFFERED
  • TABLE 320 MEDIANA CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 321 PROGETTI SRL: COMPANY OVERVIEW
  • TABLE 322 PROGETTI SRL: PRODUCTS OFFERED
  • TABLE 323 PROGETTI SRL: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 324 SCHILLER AG: COMPANY OVERVIEW
  • TABLE 325 SCHILLER AG: PRODUCTS OFFERED
  • TABLE 326 SCHILLER AG.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 327 SCHILLER AG.: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
  • TABLE 328 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 329 METRAX GMBH: COMPANY OVERVIEW
  • TABLE 330 MS WESTFALIA GMBH: COMPANY OVERVIEW
  • TABLE 331 BEXEN CARDIO: COMPANY OVERVIEW
  • TABLE 332 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: COMPANY OVERVIEW
  • TABLE 333 AVIVE SOLUTIONS: COMPANY OVERVIEW
  • TABLE 334 AMI ITALIA: COMPANY OVERVIEW
  • TABLE 335 CORPLUS: COMPANY OVERVIEW
  • TABLE 336 ALLIED MEDICAL LTD.: COMPANY OVERVIEW
  • TABLE 337 AXION CONCERN LLC: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 DEFIBRILLATOR MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 DEFIBRILLATOR MARKET: YEARS CONSIDERED
  • FIGURE 3 DEFIBRILLATOR MARKET: RESEARCH DESIGN
  • FIGURE 4 DEFIBRILLATOR MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5 DEFIBRILLATOR MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 6 DEFIBRILLATOR MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS)
  • FIGURE 7 DEFIBRILLATOR MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 9 DEFIBRILLATOR MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2024
  • FIGURE 10 DEFIBRILLATOR MARKET: MARKET SIZE ESTIMATION
  • FIGURE 11 DEFIBRILLATOR MARKET: TOP-DOWN APPROACH
  • FIGURE 12 DEFIBRILLATOR MARKET: CAGR PROJECTIONS (SUPPLY SIDE)
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 DEFIBRILLATOR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023 VS. 2030
  • FIGURE 20 DEFIBRILLATOR MARKET, BY END USER, 2025 VS. 2030
  • FIGURE 21 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATOR MARKET
  • FIGURE 22 RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • FIGURE 23 HOSPITALS & CLINICS SEGMENT AND CHINA LED DEFIBRILLATOR MARKET IN 2024
  • FIGURE 24 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 25 DEFIBRILLATOR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR DEFIBRILLATOR MARKET
  • FIGURE 27 AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 28 DEFIBRILLATOR MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 29 DEFIBRILLATOR MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 DEFIBRILLATOR MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 DEFIBRILLATOR MARKET: INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • FIGURE 32 DEFIBRILLATOR MARKET: PATENT ANALYSIS, JANUARY 2014-JUNE 2025
  • FIGURE 33 DEFIBRILLATOR MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DEFIBRILLATOR
  • FIGURE 35 KEY BUYING CRITERIA FOR DEFIBRILLATOR, BY PRODUCT
  • FIGURE 36 DEFIBRILLATOR MARKET: AI USE CASES
  • FIGURE 37 NORTH AMERICA: DEFIBRILLATOR MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: DEFIBRILLATOR MARKET SNAPSHOT
  • FIGURE 39 DEFIBRILLATOR MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2022-2024
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICDS) MARKET, 2024
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EXTERNAL DEFIBRILLATOR MARKET, 2024
  • FIGURE 42 RANKING OF KEY PLAYERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, 2024
  • FIGURE 43 EV/EBITDA OF KEY VENDORS
  • FIGURE 44 YEAR-TO-DATE PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 45 DEFIBRILLATOR MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 46 DEFIBRILLATOR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 47 DEFIBRILLATOR MARKET: COMPANY FOOTPRINT
  • FIGURE 48 DEFIBRILLATOR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024)
  • FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 51 ABBOTT: COMPANY SNAPSHOT (2024)
  • FIGURE 52 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 53 STRYKER: COMPANY SNAPSHOT (2024)
  • FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)
  • FIGURE 55 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 56 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 57 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2024)